content is ABCA1, a sterol-induced membrane protein that mediates the transport of excess cholesterol from cells to lipid-poor apolipoprotein (apo)A-I, the major protein component of HDLs ( 1 ). Mutations in human ABCA1 are associated with a severe HDL defi ciency, cholesterol deposition in tissue macrophages, and prevalent cardiovascular disease ( 2 ). Over-expressing ABCA1 in mice signifi cantly decreases atherosclerosis ( 3 ), whereas ablating ABCA1 in stem-cell transferred mouse macrophages increases atherosclerotic lesions ( 4, 5 ). Thus, ABCA1 plays a critical role in protecting against cardiovascular disease.We showed previously that diabetes-associated metabolic factors impair ABCA1 function by destabilizing the protein in vitro . Reactive carbonyl precursors for advance glycation end products (AGEs), which are increased in both types 1 and 2 diabetes ( 6-9 ), acutely and severely suppress ABCA1 cholesterol export activity and reduce ABCA1 protein levels in cultured cells ( 10 ). Unsaturated fatty acids, which can be elevated in poorly controlled type 1 diabetes and are often elevated in type 2 diabetes and the metabolic syndrome ( 11-13 ), increase ABCA1 degradation through a phospholipase D/protein kinase C ␦ signaling pathway that phosphorylates ABCA1 serines ( 14-17 ).These studies raise the possibility that diabetes impairs the ABCA1 cholesterol export pathway in vivo, leading to increased accumulation of cholesterol in arterial macrophages and enhanced atherogenesis (18)(19)(20). In support of this idea are our studies showing that inducing diabetes in cholesterol-fed swine markedly increased atherosclerotic lesion size in association with a dramatic reduction in the level of immunodectable ABCA1 in lesion foam-cell macrophages ( 10 ).Here, we examined the effects of type 1 diabetes on ABCA1 protein and mRNA levels in mouse macrophages and tissues. Results show that inducing diabetes in two different type 1 diabetic mouse models reduced the ABCA1 protein content of peritoneal macrophages and the kidAbstract Accumulation of cholesterol in arterial macrophages may contribute to diabetes-accelerated atherosclerotic cardiovascular disease. The ATP-binding cassette transporter ABCA1 is a cardioprotective membrane protein that mediates cholesterol export from macrophages. Factors elevated in diabetes, such as reactive carbonyls and free fatty acids, destabilize ABCA1 protein in cultured macrophages, raising the possibility that impaired ABCA1 plays an atherogenic role in diabetes. We therefore examined the modulation of ABCA1 in two mouse models of diabetes. We isolated peritoneal macrophages, livers, kidneys, and brains from type 1 non-obese diabetic (NOD) mice and mice made diabetic by viral-induced autoimmune destruction of pancreatic  -cells, and we measured ABCA1 protein and mRNA levels and cholesterol contents. ABCA1 protein levels and cholesterol export activity were reduced by 40-44% ( P < 0.01) in peritoneal macrophages and protein levels by 48% ( P < 0.001) in kidneys in diabetic NOD mice comp...